Tim Whitten

Tim Whitten serves as a member of the Board of Directors at Astex Pharmaceuticals, Inc. since September 2022 and has been the CEO & President of TAIHO ONCOLOGY INC since April 2017, where also serves as Chief Operating Officer. Previously, Tim held the position of Chief Commercial Officer at Taiho Oncology, Inc. from February 2013 to March 2017, responsible for building a commercial organization in the U.S. Prior roles include President & CEO at Insmed and Transave Inhalation Biotherapeutics, along with senior leadership positions at Pharmacyclics and Bristol-Myers Squibb, where Tim contributed significantly to oncology and immunology marketing. Tim holds a Bachelor of Science degree in Pharmacy from West Virginia University and an MBA from the University of Virginia Darden School of Business.